Stirnemann J, Belmatoug N, Camou F, et al. A review of Gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci. 2017;18:441.

Article  PubMed  PubMed Central  Google Scholar 

Revel-Vilk S, Szer J, Zimran A. Gaucher disease and related lysosomal storage diseases. In: Williams Hematology, 10th ed.; Kaushansky K, Lichtman M, Prchal J, Levi M, Press O, Burns L, Caligiuri M, Eds. McGraw-Hill: New York, NY, USA, 2021; p. 1189–202

Van Rossum A, Holsopple M. Enzyme replacement or substrate reduction? A review of Gaucher disease treatment options. Hosp Pharm. 2016;51:553–63.

Article  PubMed  PubMed Central  Google Scholar 

Lukina E, Balwani M, Belmatoug N, et al. Pregnancy outcome in women with Gaucher disease type 1 who had unplanned pregnancies during eliglustat clinical trials. JIMD Rep. 2021;57:76–84.

Article  PubMed  Google Scholar 

Boot RG, Renkema GH, Verhoek M, et al. The human chitotriosidase gene: nature of inherited enzyme deficiency. J Biol Chem. 1998;273:25680–5.

Article  PubMed  Google Scholar 

Muranjan M, Patil S. Outcome of Gaucher disease in India: lessons from prevalent diagnostic and therapeutic practices. Indian Pediatr. 2016;53:685–8.

Article  PubMed  Google Scholar 

Nagral A. Gaucher disease J Clin Exp Hepatol. 2014;4:37–50.

Article  PubMed  Google Scholar 

Arikan-Ayyildiz Z, Yüce A, Emre S, Baysoy G, Saltik-Temizel IN, Gürakan F. Outcome of enzyme replacement therapy in Turkish patients with Gaucher disease: does late intervention affect the response? Turk J Pediatr. 2011;53:499–507.

PubMed  Google Scholar 

Andersson H, Kaplan P, Kacena K, Yee J. Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1. Pediatrics. 2008;122:1182–90.

Article  PubMed  Google Scholar 

Rosnes JS, Sharkey MF, Veille JC, Mueller-Heubach E. Gaucher’s disease in pregnancy. Obstet Gynecol Surv. 1996;51:549–58.

Article  PubMed  Google Scholar 

Lau H, Belmatoug N, Deegan P, et al. Reported outcomes of 453 pregnancies in patients with Gaucher disease: an analysis from the Gaucher outcome survey. Blood Cells Mol Dis. 2018;68:226–31.

Article  PubMed  Google Scholar 

Stein P, Malhotra A, Haims A, Pastores GM, Mistry PK. Focal splenic lesions in type I Gaucher disease are associated with poor platelet and splenic response to macrophage-targeted enzyme replacement therapy. J Inherit Metab Dis. 2010;33:769–74.

Article  PubMed  PubMed Central  Google Scholar 

Tseng SY, Niu DM, Chu TH, et al. Very rare condition of multiple Gaucheroma: a case report and review of the literature. Mol Genet Metabol Rep. 2019;20:100473.

Google Scholar 

Yano S, Moseley K, Mahajan N, Warren M, Vachon L. Large mesenteric Gaucheroma responds to substrate reduction therapy: a new management of Gaucheromas. J Pediatr Genet. 2020;11:47–50.

PubMed  PubMed Central  Google Scholar 

Puri RD, Kapoor S, Kishnani PS, et al; Gaucher Disease Task Force. Diagnosis and management of Gaucher disease in India–consensus guidelines of the Gaucher Disease Task Force of the Society for Indian Academy of Medical Genetics and the Indian Academy of Pediatrics. Indian Pediatr. 2018;55:143–53.

Article  PubMed  Google Scholar